Neurocrine Biosciences, Inc. Insider Transactions
Purchase
Sell
Neurocrine Biosciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 980 @ $118.22 | $115,853 | 33,253 | 02/10/2025 | 02/12/2025 | |
|
Lippoldt Darin
Chief Legal Officer |
Sell | 911 @ $118.25 | $107,727 | 41,679 | 02/10/2025 | 02/12/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 980 @ $118.31 | $115,940 | 42,799 | 02/10/2025 | 02/12/2025 | |
|
Gano Kyle
CEO |
Sell | 980 @ $118.39 | $116,020 | 137,658 | 02/10/2025 | 02/12/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 980 @ $118.27 | $115,909 | 33,561 | 02/10/2025 | 02/12/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 700 @ $118.31 | $82,820 | 1,998 | 02/10/2025 | 02/12/2025 | |
|
Delaet Ingrid
Chief Regulatory Officer |
Sell | 623 @ $149.29 | $93,008 | 3,442 | 02/03/2025 | 02/04/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 1,207 @ $152.94 | $184,599 | 41,919 | 01/31/2025 | 02/04/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 1,283 @ $152.87 | $196,136 | 32,681 | 01/31/2025 | 02/04/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 2,707 @ $152.92 | $413,967 | 517,030 | 01/31/2025 | 02/04/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 1,457 @ $152.80 | $222,636 | 32,373 | 01/31/2025 | 02/04/2025 | |
|
Onyia Jude
Chief Scientific Officer |
Sell | 126 @ $152.97 | $19,274 | 15,561 | 01/31/2025 | 02/04/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 1,104 @ $152.94 | $168,849 | 1,369 | 01/31/2025 | 02/04/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 824 @ $152.89 | $125,980 | 18,202 | 01/31/2025 | 02/04/2025 | |
|
Lippoldt Darin
Chief Legal Officer |
Sell | 1,250 @ $152.91 | $191,133 | 40,863 | 01/31/2025 | 02/04/2025 | |
|
Gano Kyle
CEO |
Sell | 1,541 @ $152.87 | $235,577 | 136,778 | 01/31/2025 | 02/04/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 916 @ $152.89 | $140,045 | 19,026 | 01/31/2025 | 02/04/2025 | |
|
Delaet Ingrid
Chief Regulatory Officer |
Sell | 422 @ $153.05 | $64,587 | 2,886 | 01/31/2025 | 02/04/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 146,105 @ $149.46 | $21.84 M | 514,596 | 01/27/2025 | 01/29/2025 | |
|
Gano Kyle
CEO |
Sell | 60,188 @ $141.50 | $8.52 M | 135,392 | 01/15/2025 | 01/17/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. FAQ's
The list of insiders at Neurocrine Biosciences, Inc. includes Delaet Ingrid, Gano Kyle, GORMAN KEVIN CHARLES, Lippoldt Darin, ABERNETHY MATT, BENEVICH ERIC, Boyer David W., Onyia Jude, ROBERTS EIRY, Cooke Julie.
Insiders have sold a total of 231,459 Neurocrine Biosciences, Inc. shares in the last 12 months for a total of 33.93 M sold.
The following insiders have sold Neurocrine Biosciences, Inc. shares in the last 12 months: Delaet Ingrid ($342,443), Gano Kyle ($9.55 M), GORMAN KEVIN CHARLES ($22.25 M), Lippoldt Darin ($298,860), ABERNETHY MATT ($312,044), BENEVICH ERIC ($300,539), Boyer David W. ($251,669), Onyia Jude ($19,274), ROBERTS EIRY ($338,489), Cooke Julie ($266,025),
The list of congress members trading at Neurocrine Biosciences, Inc. includes Michael McCaul.